# The HEADWIND Study - Part 3

> **NCT05183191** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 11 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **OTHER:** Controlled hypoglycaemic state while driving with a driving simulator

## Key facts

- **NCT ID:** NCT05183191
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-29
- **Primary completion:** 2022-03-03
- **Final completion:** 2022-03-03
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2022-05-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05183191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05183191, "The HEADWIND Study - Part 3". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05183191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*